LexaGene Holdings Inc.
LXXGF · OTC
2/28/2022 | 2/28/2021 | 2/29/2020 | 2/28/2019 | |
|---|---|---|---|---|
| Market Cap | $27,594 | $22,083 | $16,279 | $13,588 |
| - Cash | $4,723 | $9,624 | $3,186 | $671 |
| + Debt | $1,247 | $1,595 | $1,917 | $0 |
| Enterprise Value | $24,119 | $14,054 | $15,010 | $12,917 |
| Revenue | $75 | $58 | $0 | $0 |
| % Growth | 29.6% | – | – | – |
| Gross Profit | -$468 | -$101 | $0 | $0 |
| % Margin | -621.4% | -173.8% | – | – |
| EBITDA | -$10,053 | -$9,295 | -$6,893 | -$8,187 |
| % Margin | -13,348.1% | -15,991.4% | – | – |
| Net Income | -$10,620 | -$9,966 | -$7,601 | -$8,320 |
| % Margin | -14,101% | -17,145.8% | – | – |
| EPS Diluted | -0.09 | -0.096 | -0.1 | -0.13 |
| % Growth | 6.4% | 3.3% | 23.5% | – |
| Operating Cash Flow | -$9,646 | -$9,045 | -$5,413 | -$5,999 |
| Capital Expenditures | -$18 | -$68 | -$453 | -$141 |
| Free Cash Flow | -$9,664 | -$9,113 | -$5,866 | -$6,140 |